cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina and currently employs 42 full-time employees. The company went IPO on 2017-11-17. The firm has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The firm's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Follow-Up Questions
Who is the CEO of cbdMD Inc?
Mr. T. Ronan Kennedy is the Chief Executive Officer of cbdMD Inc, joining the firm since 2020.
What is the price performance of YCBD stock?
The current price of YCBD is $0.846, it has increased 0.59% in the last trading day.
What are the primary business themes or industries for cbdMD Inc?
cbdMD Inc belongs to Pharmaceuticals industry and the sector is Health Care
What is cbdMD Inc market cap?
cbdMD Inc's current market cap is $7.5M
Is cbdMD Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for cbdMD Inc, including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell
